VIRGINIA REBOLLAR: Open Payments
NPI 1285213470 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,250 in 187 payments from 17 companies in 2025. Trend: 2023 $2,114 · 2024 $2,938 · 2025 $3,250
Food & beverage: $3,228Speaker / faculty: $22
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 48 | $1,041 |
| ABBVIE INC. | 32 | $668 |
| ACADIA Pharmaceuticals Inc | 55 | $520 |
| Teva Pharmaceuticals USA, Inc. | 13 | $235 |
| MDD US Operations, LLC | 10 | $218 |
| Amneal Pharmaceuticals LLC | 12 | $194 |
| Merz Pharmaceuticals, LLC | 3 | $71 |
| PFIZER INC. | 3 | $53 |
| Ipsen Biopharmaceuticals, Inc | 2 | $50 |
| Lilly USA, LLC | 2 | $34 |
Products named: INGREZZA, NUPLAZID, VYALEV, BOTOX, AUSTEDO XR, CREXONT, QULIPTA, Xeomin.
Industry payments across TX — which companies pay providers there.
